Online citations, reference lists, and bibliographies.
← Back to Search

Phase III, Open-label, Randomized, Comparative Study Of Tremelimumab (CP-675,206) And Chemotherapy (temozolomide [TMZ] Or Dacarbazine [DTIC]) In Patients With Advanced Melanoma

A. Ribas, A. Hauschild, R. Kefford, C. J. Punt, J. B. Haanen, M. Marmol, C. Garbe, J. Gomez-Navarro, D. Pavlov, M. Marshall

Save to my Library
Download PDF
Analyze on Scholarcy
Share